Literature DB >> 16705172

Novel lymphotoxin alpha (LTalpha) knockout mice with unperturbed tumor necrosis factor expression: reassessing LTalpha biological functions.

Dmitry J Liepinsh1, Sergei I Grivennikov, Kimberly D Klarmann, Maria A Lagarkova, Marina S Drutskaya, Stephen J Lockett, Lino Tessarollo, Matthew McAuliffe, Jonathan R Keller, Dmitry V Kuprash, Sergei A Nedospasov.   

Abstract

Lymphotoxin alpha (LTalpha) can exist in soluble form and exert tumor necrosis factor (TNF)-like activity through TNF receptors. Based on the phenotypes of knockout (KO) mice, the physiological functions of LTalpha and TNF are considered partly redundant, in particular, in supporting the microarchitecture of the spleen and in host defense. We exploited Cre-LoxP technology to generate a novel neomycin resistance gene (neo) cassette-free LTalpha-deficient mouse strain (neo-free LTalpha KO [LTalphaDelta/Delta]). Unlike the "conventional" LTalpha-/- mice, new LTalphaDelta/Delta animals were capable of producing normal levels of systemic TNF upon lipopolysaccharide (LPS) challenge and were susceptible to LPS/D-galactosamine (D-GalN) toxicity. Activated neutrophils, monocytes, and macrophages from LTalphaDelta/Delta mice expressed TNF normally at both the mRNA and protein levels as opposed to conventional LTalpha KO mice, which showed substantial decreases in TNF. Additionally, the spleens of the neo-free LTalpha KO mice displayed several features resembling those of LTbeta KO mice rather than conventional LTalpha KO animals. The phenotype of the new LTalphaDelta/Delta mice indicates that LTalpha plays a smaller role in lymphoid organ maintenance than previously thought and has no direct role in the regulation of TNF expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16705172      PMCID: PMC1489085          DOI: 10.1128/MCB.01751-05

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

Review 1.  Toll-like receptor control of the adaptive immune responses.

Authors:  Akiko Iwasaki; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2004-10       Impact factor: 25.606

2.  Tumour necrosis factor and lymphotoxin genes map close to H-2D in the mouse major histocompatibility complex.

Authors:  U Müller; C V Jongeneel; S A Nedospasov; K F Lindahl; M Steinmetz
Journal:  Nature       Date:  1987 Jan 15-21       Impact factor: 49.962

3.  Independent protective effects for tumor necrosis factor and lymphotoxin alpha in the host response to Listeria monocytogenes infection.

Authors:  D R Roach; H Briscoe; B M Saunders; W J Britton
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells.

Authors:  K Hestdal; F W Ruscetti; J N Ihle; S E Jacobsen; C M Dubois; W C Kopp; D L Longo; J R Keller
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

5.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

6.  Roles of Listeria monocytogenes virulence factors in survival: virulence factors distinct from listeriolysin are needed for the organism to survive an early neutrophil-mediated host defense mechanism.

Authors:  J W Conlan; R J North
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

7.  Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection.

Authors:  A Nakane; T Minagawa; K Kato
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

8.  Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection.

Authors:  K Pfeffer; T Matsuyama; T M Kündig; A Wakeham; K Kishihara; A Shahinian; K Wiegmann; P S Ohashi; M Krönke; T W Mak
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

9.  Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface.

Authors:  J L Browning; A Ngam-ek; P Lawton; J DeMarinis; R Tizard; E P Chow; C Hession; B O'Brine-Greco; S F Foley; C F Ware
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

10.  Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages.

Authors:  A N Shakhov; M A Collart; P Vassalli; S A Nedospasov; C V Jongeneel
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

View more
  15 in total

1.  Deficiency of lymphotoxin-α does not exacerbate high-fat diet-induced obesity but does enhance inflammation in mice.

Authors:  Nathalie Pamir; Timothy S McMillen; Kimberly A Edgel; Francis Kim; Renée C LeBoeuf
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-02-07       Impact factor: 4.310

Review 2.  Follicular dendritic cell networks of primary follicles and germinal centers: phenotype and function.

Authors:  Christopher D C Allen; Jason G Cyster
Journal:  Semin Immunol       Date:  2008-02-07       Impact factor: 11.130

3.  Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune disease.

Authors:  Eugene Y Chiang; Ganesh A Kolumam; Xin Yu; Michelle Francesco; Sinisa Ivelja; Ivan Peng; Peter Gribling; Jean Shu; Wyne P Lee; Canio J Refino; Mercedesz Balazs; Andres Paler-Martinez; Allen Nguyen; Judy Young; Kai H Barck; Richard A D Carano; Ron Ferrando; Lauri Diehl; Devavani Chatterjea; Jane L Grogan
Journal:  Nat Med       Date:  2009-06-28       Impact factor: 53.440

Review 4.  Lymphotoxin and TNF: how it all began-a tribute to the travelers.

Authors:  Nancy H Ruddle
Journal:  Cytokine Growth Factor Rev       Date:  2014-02-12       Impact factor: 7.638

Review 5.  Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Authors:  Bharat B Aggarwal; Subash C Gupta; Bokyung Sung
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

6.  An ENU-induced mutation in the lymphotoxin alpha gene impairs organogenesis of lymphoid tissues in C57BL/6 mice.

Authors:  Hongsheng Wang; Jianxun Feng; Chenfeng Qi; Herbert C Morse
Journal:  Biochem Biophys Res Commun       Date:  2008-03-31       Impact factor: 3.575

7.  Monocyte chemoattractant protein-1 (MCP-1), not MCP-3, is the primary chemokine required for monocyte recruitment in mouse peritonitis induced with thioglycollate or zymosan A.

Authors:  Munehisa Takahashi; Carole Galligan; Lino Tessarollo; Teizo Yoshimura
Journal:  J Immunol       Date:  2009-07-29       Impact factor: 5.422

8.  Unique CD8+ T Cell-Mediated Immune Responses Primed in the Liver.

Authors:  Jason M Zimmerer; Phillip H Horne; Mason G Fisher; Thomas A Pham; Keri E Lunsford; Bryce A Ringwald; Christina L Avila; Ginny L Bumgardner
Journal:  Transplantation       Date:  2016-09       Impact factor: 4.939

Review 9.  Lymphotoxin α revisited: general features and implications in rheumatoid arthritis.

Authors:  Flavia Calmon-Hamaty; Bernard Combe; Michael Hahne; Jacques Morel
Journal:  Arthritis Res Ther       Date:  2011-07-26       Impact factor: 5.156

10.  Maspin is not required for embryonic development or tumour suppression.

Authors:  Sonia S Y Teoh; Jessica Vieusseux; Monica Prakash; Susan Berkowicz; Jennii Luu; Catherina H Bird; Ruby H P Law; Carlos Rosado; John T Price; James C Whisstock; Phillip I Bird
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.